Functional production of a soluble and secreted single-chain antibody by a bacterial secretion system

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Cheng, Chiu Min ^a   Tzou, Shey Cherng ^b   Zhuang, Ya Han ^c   Huang, Chien Chiao ^c   Kao, Chien Han ^c   Liao, Kuang Wen ^b   Cheng, Ta Chun ^c   Chuang, Chih Hung ^c   Hsieh, Yuan Chin ^c   Tai, Ming Hong ^d   Cheng, Tian Lu ^c,d,e  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; PROTEIN OSMY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR; ESCHERICHIA COLI PROTEIN; OSMY PROTEIN, E COLI; PERIPLASMIC BINDING PROTEIN; PRIMER DNA; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; BACTERIAL SECRETION SYSTEM; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NONHUMAN; PERIPLASMIC LEADER SEQUENCE; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN STRUCTURE; BIOREACTOR; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PROCEDURES; WESTERN BLOTTING;

BACTERIAL SECRETION SYSTEMS; BIOREACTORS; BLOTTING, WESTERN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; INDUSTRIAL MICROBIOLOGY; PERIPLASMIC BINDING PROTEINS; PROTEIN SORTING SIGNALS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SINGLE-CHAIN ANTIBODIES;

EID: 84901249642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097367     Document Type: Article

References (29)

1. Ahmad ZA, Yeap SK, Ali AM, Ho WY, Alitheen NB, et al. (2012) scFv antibody: principles and clinical application. Clin Dev Immunol 2012: 980250.
2. Lorberboum-Galski H (2011) Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases. Expert Opin Drug Deliv 8: 605-621.
3. Reinartz S, Wagner U, Giffels P, Gruenn U, Schlebusch H, et al. (2000) Immunological properties of a single-chain fragment of the anti-idiotypic antibody ACA125. Cancer Immunol Immunother 49: 186-192. (Pubitemid 30484825)
4. de Marco A (2011) Biotechnological applications of recombinant single-domain antibody fragments. Microb Cell Fact 10: 44.
5. Huang L, Su X, Federoff HJ (2013) Single-chain fragment variable passive immunotherapies for neurodegenerative diseases. Int J Mol Sci 14: 19109-19127.
6. Kim H, Park S, Lee HK, Chung J (2013) Application of bispecific antibody against antigen and hapten for immunodetection and immunopurification. Exp Mol Med 45: e43.
7. Arbabi-Ghahroudi M, Tanha J, MacKenzie R (2005) Prokaryotic expression of antibodies. Cancer Metastasis Rev 24: 501-519. (Pubitemid 43096998)
8. Ni Y, Chen R (2009) Extracellular recombinant protein production from Escherichia coli. Biotechnol Lett 31: 1661-1670.
9. Kipriyanov SM, Little M, Kropshofer H, Breitling F, Gotter S, et al. (1996) Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. Protein Eng 9: 203-211. (Pubitemid 26119301)
10. Smallshaw JE, Georges F, Lee JS, Waygood EB (1999) Synthesis, cloning and expression of the single-chain Fv gene of the HPr-specific monoclonal antibody, Jel42. Determination of binding constants with wild-type and mutant HPrs. Protein Eng 12: 623-630. (Pubitemid 29368970)
11. Jurado P, de Lorenzo V, Fernandez LA (2006) Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of thioredoxin. J Mol Biol 357: 49-61. (Pubitemid 43339313)
12. Hu X, O'Hara L, White S, Magner E, Kane M, et al. (2007) Optimisation of production of a domoic acid-binding scFv antibody fragment in Escherichia coli using molecular chaperones and functional immobilisation on a mesoporous silicate support. Protein Expr Purif 52: 194-201. (Pubitemid 46038745)
13. Choi JH, Lee SY (2004) Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 64: 625-635. (Pubitemid 38822625)
14. Yoon SH, Kim SK, Kim JF(2010) Secretory production of recombinant proteins in Escherichia coli. Recent Pat Biotechnol 4: 23-29.
15. Makabe K, Nakanishi T, Tsumoto K, Tanaka Y, Kondo H, et al. (2008) Thermodynamic consequences of mutations in vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody, 528. J Biol Chem 283: 1156-1166.
16. Cheng CM, Lu YL, Chuang KH, Hung WC, Shiea J, et al. (2008) Tumortargeting prodrug-activating bacteria for cancer therapy. Cancer Gene Ther 15: 393-401. (Pubitemid 351693224)
17. Ilk N, Schumi CT, Bohle B, Egelseer EM, Sleytr UB (2011) Expression of an endotoxin- free S-layer/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergy. Microb Cell Fact 10: 6.
18. Francetic O, Belin D, Badaut C, Pugsley AP (2000) Expression of the endogenous type II secretion pathway in Escherichia coli leads to chitinase secretion. EMBO J 19: 6697-6703. (Pubitemid 32011662)
19. Low KO, Mahadi NM, Rahim RA, Rabu A, Abu Bakar FD, et al. (2011)An effective extracellular protein secretion by an ABC transporter system in Escherichia coli: statistical modeling and optimization of cyclodextrin glucano-transferase secretory production. J Ind Microbiol Biotechnol 38: 1587-1597.
20. Qian ZG, Xia XX, Choi JH, Lee SY (2008) Proteome-based identification of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli. Biotechnol Bioeng 101: 587-601.
21. Zheng Z, Chen T, Zhao M, Wang Z, Zhao X (2012) Engineering Escherichia coli for succinate production from hemicellulose via consolidated bioprocessing. Microb Cell Fact 11: 37.
22. Kotzsch A, Vernet E, Hammarstrom M, Berthelsen J, Weigelt J, et al. (2011) A secretory system for bacterial production of high-profile protein targets. Protein Sci 20: 597-609.
23. Chi SC, Shieh JR, Lin SJ (2003) Genetic and antigenic analysis of betanodaviruses isolated from aquatic organisms in Taiwan. Dis Aquat Organ 55: 221-228. (Pubitemid 37065199)
24. Shieh JR, Chi SC (2005) Production of monoclonal antibodies against grouper nervous necrosis virus (GNNV) and development of an antigen capture ELISA. Dis Aquat Organ 63: 53-60. (Pubitemid 40263273)
25. Darwich L, Mateu E (2012) Immunology of porcine circovirus type 2 (PCV2). Virus Res 164: 61-67.
26. Gamage LN, McIntosh KA, Parker S, Harding J, Krakowka S, et al. (2012)Efficacy of parenteral vaccination against porcine circovirus type 2 (PCV2) in seropositive piglets. Can J Vet Res 76: 301-307.
27. Ralph JP, Catcheside DE (1999) Transformation of macromolecules from a brown coal by lignin peroxidase. Appl Microbiol Biotechnol 52: 70-77. (Pubitemid 29364544)
28. Intorasoot S, Tanaka H, Shoyama Y, Leelamanit W (2007) Characterization and diagnostic use of a recombinant single-chain antibody specific for the gp116 envelop glycoprotein of Yellow head virus. J Virol Methods 143: 186-193. (Pubitemid 46970862)
29. Makrides SC (1996) Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev 60: 512-538.